Display options
Cite
Lavorgna L, Iaffaldano P, Abbadessa G, et al. Disability assessment using Google Maps. Neurol Sci. 2021;doi: 10.1007/s10072-021-05389-7.
Lavorgna, L., Iaffaldano, P., Abbadessa, G., Lanzillo, R., Esposito, S., Ippolito, D., Sparaco, M., Cepparulo, S., Lus, G., Viterbo, R., Clerico, M., Trojsi, F., Ragonese, P., Borriello, G., Signoriello, E., Palladino, R., Moccia, M., Brigo, F., Troiano, M., Tedeschi, G., & Bonavita, S. (2021). Disability assessment using Google Maps. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, . https://doi.org/10.1007/s10072-021-05389-7
Lavorgna, Luigi, et al. "Disability assessment using Google Maps." Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology vol. (2021). doi: https://doi.org/10.1007/s10072-021-05389-7
Lavorgna L, Iaffaldano P, Abbadessa G, Lanzillo R, Esposito S, Ippolito D, Sparaco M, Cepparulo S, Lus G, Viterbo R, Clerico M, Trojsi F, Ragonese P, Borriello G, Signoriello E, Palladino R, Moccia M, Brigo F, Troiano M, Tedeschi G, Bonavita S. Disability assessment using Google Maps. Neurol Sci. 2021 Jun 17; doi: 10.1007/s10072-021-05389-7. Epub 2021 Jun 17. PMID: 34142263; PMCID: PMC8211455.
Copy Download .nbib Format: NLM
Share it on

Neurol Sci. 2021 Jun 17; doi: 10.1007/s10072-021-05389-7. Epub 2021 Jun 17.

Disability assessment using Google Maps.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Luigi Lavorgna, Pietro Iaffaldano, Gianmarco Abbadessa, Roberta Lanzillo, Sabrina Esposito, Domenico Ippolito, Maddalena Sparaco, Simone Cepparulo, Giacomo Lus, Rosa Viterbo, Marinella Clerico, Francesca Trojsi, Paolo Ragonese, Giovanna Borriello, Elisabetta Signoriello, Raffaele Palladino, Marcello Moccia, Francesco Brigo, Maria Troiano, Gioacchino Tedeschi, Simona Bonavita

Affiliations

  1. Italian Neurological Society (SIN), First Division of Neurology, Department of Advanced Medical and Surgical Sciences, AOU-University of Campania "Luigi Vanvitelli", Piazza Miraglia 2, 80138, Naples, Italy. [email protected].
  2. Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza G. Cesare 11, 70124, Bari, Italy.
  3. Second Division of Neurology, Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Via Sergio Pansini 5, 80131, Naples, Italy.
  4. Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Naples, Italy.
  5. Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Piazza Miraglia 2, 80138, Naples, Italy.
  6. Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
  7. First Division of Neurology, Department of Advanced Medical and Surgical Sciences, AOU-University of Campania "Luigi Vanvitelli", P.zza Miraglia 2, Naples, Italy.
  8. Second Division of Neurology, Department of Advanced Medical and Surgical Sciences, MRI Research Center SUN-FISM, AOU-University of Campania "Luigi Vanvitelli", via Sergio Pansini 5, 80131, Naples, Italy.
  9. Clinical and Biological Sciences Department, University of Torino, Turin, Italy.
  10. First Division of Neurology, Department of Advanced Medical and Surgical Sciences, AOU-University of Campania "Luigi Vanvitelli", P.zza Miraglia 2, 80138, Naples, Italy.
  11. Department of Experimental, Biomedicine and Clinical Neurosciences, University of Palermo, 90129, Palermo, Italy.
  12. S. Andrea Hospital, Sapienza Rome University, Rome, Italy.
  13. Federico II University, Naples, Italy.
  14. UOC di Neurologia, Ospedale Di Merano (SABES-ASDAA), Via Rossini, 5, 39012, Merano-Meran, BZ, Italy.
  15. First Division of Neurology, Department of Advanced Medical and Surgical Sciences, MRI Research Center SUN-FISM, AOU, University of Campania "Luigi Vanvitelli", Piazza Miraglia 2, 80138, Naples, Italy.

PMID: 34142263 PMCID: PMC8211455 DOI: 10.1007/s10072-021-05389-7

Abstract

OBJECTIVES: To evaluate the concordance between Google Maps® application (GM®) and clinical practice measurements of ambulatory function (e.g., Ambulation Score (AS) and respective Expanded Disability Status Scale (EDSS)) in people with multiple sclerosis (pwMS).

MATERIALS AND METHODS: This is a cross-sectional multicenter study. AS and EDSS were calculated using GM® and routine clinical methods; the correspondence between the two methods was assessed. A multinomial logistic model is investigated which demographic (age, sex) and clinical features (e.g., disease subtype, fatigue, depression) might have influenced discrepancies between the two methods.

RESULTS: Two hundred forty-three pwMS were included; discrepancies in AS and in EDDS assessments between GM® and routine clinical methods were found in 81/243 (33.3%) and 74/243 (30.4%) pwMS, respectively. Progressive phenotype (odds ratio [OR] = 2.8; 95% confidence interval [CI] 1.1-7.11, p = 0.03), worse fatigue (OR = 1.03; 95% CI 1.01-1.06, p = 0.01), and more severe depression (OR = 1.1; 95% CI 1.04-1.17, p = 0.002) were associated with discrepancies between GM® and routine clinical scoring.

CONCLUSION: GM® could easily be used in a real-life clinical setting to calculate the AS and the related EDSS scores. GM® should be considered for validation in further clinical studies.

© 2021. Fondazione Società Italiana di Neurologia.

Keywords: Ambulatory disorders; Digital health; Google Maps; e-Health

References

  1. Chatterji P, Li Y (2021) Effects of the COVID-19 pandemic on outpatient providers in the United States. Med Care 59(1):58–61 - PubMed
  2. Moccia M, Lanzillo R, Brescia Morra V et al (2020) Assessing disability and relapses in multiple sclerosis on tele-neurology. Neurol Sci 41:1369–1371 - PubMed
  3. Bombaci A, Abbadessa G, Trojsi F et al (2021) Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail. Neurol Sci 42(1):9–13 - PubMed
  4. Bove R, Bevan C, Crabtree E, Zhao C, Gomez R, Garcha P, Morrissey J, Dierkhising J, Green AJ, Hauser SL, Cree BA, Wallin MT, Gelfand JM (2019) Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis. Mult Scler 25(11):1526–1534 - PubMed
  5. Abbadessa G, Lavorgna L, Miele G et al (2021) Assessment of multiple sclerosis disability progression using a wearable biosensor: a pilot study. J Clin Med 10(6):1160 - PubMed
  6. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452 - PubMed
  7. Kruidenier LM, Nicolai SPA, Willidgendael EM et al (2009) Functional claudication distance: a reliable and valid measurement to assess functional limitation in patients intermittent claudication. BMC Cardiovasc Disord 2(9):9 - PubMed
  8. Sharrack B, Hughes RCA (1997) Reliability of distance estimation by doctors and patients: cross sectional study. BMJ 315:1652–1654 - PubMed
  9. Hohart J, Lamping D, Fitzpatrick R et al (2001) The multiple sclerosis impact scale: a new patients based outcome measures. Brain 124:962–973 - PubMed
  10. PiriÇinar B, GüvenYorgun K (2018) What we learned from the history of multiple sclerosis measurement: expanded disability status scale. Arch Neuropsychiatry 55(Supplement 1):69–75 - PubMed
  11. Sparaco M, Lavorgna L, Conforti R et al (2018) The role of wearable devices in multiple sclerosis. Mult Scler Int 2018:7627643 - PubMed
  12. Krupp LB, LaRocca NG, Muir-Nash J et al (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123 - PubMed
  13. Hind D, Kaklamanou D, Beever D et al (2016) The assessment of depression in people with multiple sclerosis: a systematic review of psychometric validation studies. BMC Psychiatry 16:278 - PubMed
  14. Goldman MD, Motl RW, Rudick RA (2010) Possible clinical outcome measures for clinical trials in patients with multiple sclerosis. Ther Adv Neurol Disord 3:229–239 - PubMed
  15. Confavreux C, Vukusic S, Adeline P (2003) Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126:770–782 - PubMed
  16. Confavreux C, Vukusic S, Moreau T, Adeleine P (2000) Relapses and progression of disability in multiple sclerosis. N Eng J Med 343:1430–1438 - PubMed
  17. Kimmelman J, Mogil JS, Dirnagl U (2014) Distinguishing between exploratory and confirmatory preclinical research will improve translation. Plos Biol 12(5):e1001863 - PubMed
  18. Arain M, Campbell MJ, Cooper CL, Lancaster GA (2010) What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol 10:67 - PubMed
  19. Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15(2):155–163 - PubMed
  20. Mukaka MM (2012) A guide to appropriate use of Correlation coefficient in medical research MM Mukaka. Malawi Med J 24(3):69–71 - PubMed
  21. Mandrekar JN (2011) Measures of interrater agreement. J Thorac Oncol 6(1):6–7 - PubMed
  22. Dong Y, Peng CY (2013) Principled missing data methods for researchers. Springerplus 2(1):222. Published 2013 May 14. https://doi.org/10.1186/2193-1801-2-222 . - PubMed
  23. Herbolsheimer F, Riepe M, Peter R (2018) Cognitive function and the agreement between self-reported and accelerometer-accessed physical activity. BMC Geriatr 18:56 - PubMed
  24. Kalron A, Aloni R (2018) Contrasting relationship between depression, quantitative gait characteristics and self-report walking difficulties in people with multiple sclerosis. Mult Scler Relat Disord 19:1–5 - PubMed
  25. Dalgas U, Langeskov-Christensen M, Skjerbæk AG (2018) Is the impact of fatigue related to walking capacity and perceived ability in persons with multiple sclerosis? A multicenter study. J Neurol Sci 387:179–186 - PubMed
  26. Berger W, Payne MWC, Morrow SA (2017) Self reported maximum walking distance in persons with MS may affect the EDSS. Neurol Sci 379:77–80 - PubMed
  27. Neil BA, Kenneth EG, Darryl GT et al (2000) Self-Reported walking ability predicts functional mobility performance in frail older adults. JAGS 48:1408–1413 - PubMed
  28. Giantomaso T, Makowsky L, Ashworth N et al (2003) The validity of patient and physician estimate of walking distance. Clin Rehabil 17:394–401 - PubMed
  29. Minden SL, Frankel D, Hadden L et al (2004) Disability in elderly people with multiple sclerosis: an analysis of baseline data from the Sonya Slifka longitudinal multiple sclerosis study. Neurorehabilitation 19(1):55–67 - PubMed
  30. Skjerbæk AG, Boesen F, Petersen T, Rasmussen PV, Stenager E, Nørgaard M, Feys P, Kjeldgaard-Jørgensen ML, Hvid LG, Dalgas U. (2019) Can we trust self-reported walking distance when determining EDSS scores in patients with multiple sclerosis? The Danish MS hospitals rehabilitation study. Mult Scler. 25(12):1653-1660.  https://doi.org/10.1177/1352458518795416 - PubMed

Publication Types